Trillium's TTI-1612 product receives orphan drug designation in Europe and the United States.
TORONTO, Dec. 19 /PRNewswire/ -- Trillium Therapeutics Inc. (Trillium) today announced that its gastrointestinal product, TTI-1612, has been designated an Orphan Drug by the European Medicines Agency (EMEA), and the U.S. Food and Drug Administration (FDA), for the prevention of necrotizing enterocolitis (NEC). "Orphan drug status provides...

Hormone links malnutrition and immunity.
When scientists first described leptin in 1995, they told a simple story: The hormone, secreted by fat cells into the blood, travels to the brain, where it signals how much energy the body has stored, and so leptin regulates appetite. Leptin does more than just talk to...

ENBREL Enrollment Program Expands: ENBREL(R) (etanercept) Now Available to New Patients Enrolled in Queue System As of March 31, 2001.
New Patients Interested in Joining the Enrollment Program Are Encouraged To Call 888-4-ENBREL SEATTLE, April 11 /PRNewswire/ -- The maker of ENBREL(R) (etanercept) announced today that approximately 2,500 new patients are being offered "active" status in the ENBREL Enrollment Program. Patients are offered...

Target: celiac disease: therapies aimed to complement or replace the gluten-free diet.
Not many kids can imagine a world without cereal, pizza, or cookies. But these are just a few of the foods that Stanford University biochemist Chaitan Khosla has had to teach his 6-year-old son to avoid. The boy has celiac disease, an inherited immune disorder, and it has sentenced...

ENBREL(R) (etanercept) Becomes First Product to Be Reviewed by FDA For Treatment of Psoriatic Arthritis.
Based on Need for Adequate Disease Treatment Expedited Review Is Requested SEATTLE, July 16 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) announced today the filing of a fourth supplemental biologics license application (sBLA) with the U.S. Food and Drug Administration (FDA) for ENBREL(R) (etanercept). The filing...

Immunex, Wyeth-Ayerst Initiate RADIUS, One of the Largest Longitudinal Studies Of Rheumatoid Arthritis Patients.
Study to Provide Insight into Practice Patterns, Utilization and Tolerability Of Disease Modifying Anti Rheumatic Drugs (DMARDs) and Biologic Response Modifiers SEATTLE, Aug. 13 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products Corporation (NYSE:...

Study Results Positive for Phase III Study of ENBREL(R) (etanercept) In Psoriatic Arthritis.
Immunex to Proceed With Supplemental FDA Filing SEATTLE, March 22 /PRNewswire/ -- Preliminary analysis of data from a Phase 3 clinical study, announced today by Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products Corporation (NYSE: AHP), demonstrated that psoriatic arthritis...

Multifactorial treatment urged in HCV-associated vasculitis.
ABANO TERME, ITALY -- The finding that the hepatitis C virus is implicated in the pathogenesis of cryoglobulinemic vasculitis means that therapy must address the chronic viral infection, the autoimmune dysregulation, and the potential for associated lymphoproliferative disorders, Dr. Clodoveo Ferri said at a congress on skin, rheumatism, and...

Hollis-Eden Files Investigational New Drug Application For Immune Regulating Hormone HE2200.
SAN DIEGO, March 13 /PRNewswire/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH) today announced it has submitted an investigational new drug application (IND) with the United States Food and Drug Administration (FDA) to begin human clinical trials with HE2200, an immune regulating hormone drug candidate. HE2200 has been...

Vasogen and CANVAC Announce Research Collaboration.
TORONTO, June 12 /PRNewswire/ - Vasogen Inc. (TSE:VAS; AMEX:MEW) and the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) today announced a collaboration to undertake advanced research associated with the development of Vasogen's immune modulation therapy. Dr. Rafick-Pierre Sekaly, Professor, Department of Microbiology and Immunology, University of Montreal,...